Program

CET TIME ZONE

Joint Prague-Weizmann Summer School on Drug Discovery Program

  Print Full program

Monday, October 25

Time Session/Lecture info
14:00-14:10
Opening remarks
Nir London, Weizmann Institute of Science 
14:10-15:10
Discovery methods
 
14:10-14:40
Dario Neri, ETH
From encoded combinatorial libraries to targeted therapeutics
14:40-15:10
György Miklós Keserú, Hungarian Academy of Sciences
New trends in fragment based lead discovery
15:10-15:25
Break
 
15:25-16:25
Covalent Drug Discovery
 
15:25-15:55
Gail Wrigley, AstraZeneca
A Case Study on Osimertinib: A covalent, brain penetrant inhibitor of EGFR
15:55-16:25
Daniela Angst, Novartis
Discovery of Remibrutinib, a covalent and selective BTK inhibitor

Registration deadline
October 24th, 2021

Organizing committee

  • Nir London, WIS
  • Haim Barr, WIS
  • Martin Fusek, IOCB, Prague
  • Radek Cibulka, UCT, Prague
  • Petra Menová, UCT, Prague

Sponsors

  • The Chorafas Institute for Scientific Exchange
  • Feinberg Graduate School
  • The Dr. Barry Sherman Institute for Medicinal Chemistry
  • Moross Integrated Cancer Center

 

Coordinator & Accessibility Issues

Talia Suissa
talias@weizmann.ac.il